ReAx Biotechnologies

Pre-clinical biotechnology company using chemoproteomic drug discovery to develop novel therapies for oncology and immunology by targeting previously undruggable proteins.

Location
Chicago, Illinois, USA
Founded
2021
Investors
1
Categories
biotech, chemoproteomics, drug-discovery, oncology, immunology

Investors

NameLocationTypeStagesPortfolio
Portal InnovationsUSbiotech-focused-13